Loading news...
Phibro Animal Health (NASDAQ: PAHC - Get Free Report) and Nephros (NASDAQ: NEPH - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings and profitability. Insider and Institutional Ownership 99.3% of Phibro
New initiative accelerates cross-industry engagement, expands educational reach to drive long-term growth in water quality solutions Takeaways: Nephros launched the Nephros Water Institute to formalize and expand its national leadership in water safety education. The institute provides evidence-based curricula, webinars, and tailored training for healthcare and water safety professionals.
SOUTH ORANGE, N.J., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leader in point-of-use water filtration, today announced the launch of the Nephros Water Institute, a dedicated education initiative established to formalize the company's leadership in industry education.
Nephros, Inc. ( NEPH ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Kirin Smith Robert Banks - President, CEO & Director Judy Krandel - Chief Financial Officer Conference Call Participants Thomas McGovern Ralph Weil Nick Farwell Presentation Operator Good day, and welcome to the Nephros, Inc. Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.
Third-Quarter Net Revenue of $4.8 million; Robust Growth Drives 35% Increase in Net Revenue and Fourth Consecutive Quarter of Profitability SOUTH ORANGE, NJ, November 6, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Nephros, Inc.
Third-Quarter Net Revenue of $4.8 million; Robust Growth Drives 35% Increase in Net Revenue and Fourth Consecutive Quarter of Profitability SOUTH ORANGE, NJ., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the third quarter ended September 30, 2025.
Key Takeaways SOUTH ORANGE, N.J., Oct. 30, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Nephros, Inc.
New 19-Series solution targets wide range of chemical contaminants SOUTH ORANGE, NJ, October 8, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Nephros, Inc.
SOUTH ORANGE, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to medical and commercial markets, today announced the launch of its new filter designed to reduce Total PFAS, or per- and polyfluoroalkyl substances (PFAS), in potable water.
Nephros, Inc. (NASDAQ:NEPH ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Judy F. Krandel - Chief Financial Officer Robert Banks - President, CEO & Director Conference Call Participants Thomas McGovern - Unidentified Company Kirin M.
Second-Quarter Net Revenue of $4.4 million; Robust Growth Drives 36% Increase in Net Revenue with Third Consecutive Quarter of Profitability SOUTH ORANGE, NJ, August 7, 2025 – PRISM MediaWire – Nephros, Inc.
SOUTH ORANGE, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the second quarter ended June 30, 2025.
SOUTH ORANGE, N.J., July 31, 2025 – PRISM MediaWire – Nephros, Inc.
SOUTH ORANGE, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its second-quarter financial results on Thursday, August 07, 2025 after market close and will host a conference call that same day at 4:30pm ET.
SOUTH ORANGE, N.J., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will be participating in the Benchmark Company 13th Annual Discovery One-on-One Investor Conference. The event is scheduled for Wednesday, December 11, 2024, at the New York Athletic Club in New York City.
Nephros, Inc. (NASDAQ:NEPH ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Kirin Smith - PCG Advisory Robert Banks - President & Chief Executive Officer Judy Krandel - Chief Financial Officer Conference Call Participants Jeremy Pearlman - Maxim Group Ralph Weil - R. Weil Investment Management Operator Good day, and welcome to the Nephros Inc. Third Quarter 2024 Financial Results Conference Call.
SOUTH ORANGE, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets, today announced that it will file its third-quarter financial results on Thursday, November 7, 2024 after market close and will host a conference call that same day at 4:30pm ET.
SOUTH ORANGE, N.J., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH) Nephros, Inc., a leader in advanced filtration technology, is proud to announce its rapid response to the recent hurricanes which devastated parts of the southeastern United States. Leveraging its significant disaster and emergency response capabilities, Nephros provided crucial water filtration solutions to multiple healthcare and nursing care facilities affected by the storms, ensuring a safe supply of water to patients and staff amid recovery efforts.
Nephros, Inc. (NEPH) Q2 2024 Earnings Call Transcript
Second-Quarter Net Revenue of $3.3 Million; New Accounts Help Drive Growth in Core Programmatic Business SOUTH ORANGE, NJ, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the second quarter ended June 30, 2024. Financial Highlights* Net revenue of $3.3 million, a decrease of 8% over Q2 prior year; programmatic revenue (excluding emergency response revenue) increased 8% over Q2 prior year Net loss of $0.3 million, compared to a net loss of $0.4 million Adjusted EBITDA of ($133,000), compared to ($183,000) *Stated performance is relative to same period in the prior year unless otherwise noted.